Drug-eluting stent

Coronary Stent Market Size Worth $11.3 Billion By 2027 | CAGR: 4.7%: Grand View Research, Inc.

Retrieved on: 
Tuesday, May 12, 2020
Interventional cardiology, Medicine, Medical technology, Medical devices, Medical specialties, Drug-eluting stent, Coronary stent, Stent, Percutaneous coronary intervention, Biosensors International

Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period.

Key Points: 
  • Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period.
  • Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth.
  • Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.
  • Grand View Research has segmented the global coronary stent market based on product and region:
    Coronary Stents Product Outlook (Revenue, USD Million, 2016 - 2027)

Coronary Stent Market Size Worth $11.3 Billion By 2027 | CAGR: 4.7%: Grand View Research, Inc.

Retrieved on: 
Tuesday, May 12, 2020
Interventional cardiology, Medicine, Medical technology, Medical devices, Medical specialties, Drug-eluting stent, Coronary stent, Stent, Percutaneous coronary intervention, Biosensors International

Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period.

Key Points: 
  • Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period.
  • Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth.
  • Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.
  • Grand View Research has segmented the global coronary stent market based on product and region:
    Coronary Stents Product Outlook (Revenue, USD Million, 2016 - 2027)

Global Coronary Stents Market (2020 to 2027) - Featuring Abbott, Medtronic & Boston Scientific Corporation Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 9, 2020
Medical devices, Health, Medicine, Clinical medicine, Medical devices, Interventional cardiology, Percutaneous coronary intervention, Interventional radiology, Coronary stent, Stent, Minimally invasive procedure, Medicare, Drug-eluting stent

The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%.

Key Points: 
  • The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%.
  • Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years.
  • Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.
  • The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers.

Coronary Stents Market Size, Share & Trends Analysis Report By Product, By Region And Segment Forecasts, 2020 - 2027

Retrieved on: 
Wednesday, April 8, 2020
Interventional cardiology, Medicine, Medical technology, Medical devices, Clinical medicine, Drug-eluting stent, Percutaneous coronary intervention, Stent, Coronary stent, Cordis, Julio Palmaz

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

Key Points: 
  • Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027
    The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%.
  • Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years.
  • Further key findings from the report suggest:
    In terms of revenue, the DES dominated the product segment as of 2019.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

North American Vascular Stents Market Outlook, 2019-2024 - Increasing Obesity Levels, Rising Smoking & Alcohol Consumption, Increasing Incidences of Hypertension - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 2, 2020
Medical devices, Health, Medicine, Medical technology, Medical equipment, Interventional radiology, Stent, Interventional cardiology, Drug-eluting stent, Ulrich Sigwart

The North America vascular stents market reached a value of US$ 3 Billion in 2018.

Key Points: 
  • The North America vascular stents market reached a value of US$ 3 Billion in 2018.
  • The North America vascular stents market is currently being driven by several factors.
  • What is the breakup of the North America vascular stents market on the basis of product type?
  • What is the breakup of the North America vascular stents market on the basis of mode of delivery?

Global Bio-Engineered Stent Report 2019: Market Size & Share (2017-2027), Application Analysis, Growth Trends, Key Players, Competitive Strategies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 20, 2019
Health, Biotechnology, Medical technology, Medical devices, Interventional cardiology, Medicine, Medical equipment, Biotronik, Cardiac electrophysiology, Stent, Coronary stent, Drug-eluting stent, Percutaneous coronary intervention

The "Global Bio-Engineered Stent Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Bio-Engineered Stent Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global bio-engineered stent market is growing effectively from 2019 to 2027, accredited to the rise in hospital admissions for heart disorders along with enhanced bioengineered technology expansion in the stent industry on a global scale.
  • In September 2018, Biotronik received the U.S FDA approval for coronary stent system for the management of acute coronary artery.
  • A growing number of clinical trials for future launch by global players expected to drive the growth of the market in the near future.

Coronary Stents Market Value to Hit $8 Billion by 2025: Global Market Insights, Inc.

Retrieved on: 
Wednesday, November 6, 2019
Interventional cardiology, Medicine, Medical technology, Medical devices, Medical equipment, Drug-eluting stent, Coronary stent, Stent, Medtronic, Percutaneous coronary intervention, Bare-metal stent

Increasing technological advancements associated with coronary stents, such as bifurcated stents and use of biodegradable materials are expected to prompt a rise in the market value.

Key Points: 
  • Increasing technological advancements associated with coronary stents, such as bifurcated stents and use of biodegradable materials are expected to prompt a rise in the market value.
  • Major players operating in the market are focusing primarily on design innovations to modify the stents as per patient's condition.
  • For instance, in February 2018, Medtronic plc announced the launch of Resolute Onyx 2.0 mm Drug-Eluting Stent (DES); the smallest DES in the coronary stents market.
  • Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services.

Global Vascular Stent Market Analysis, Trends, and Forecasts Report 2019: Market is Projected to Grow by US$8.7 Billion - ResearchAndMarkets.com

Retrieved on: 
Monday, October 7, 2019
Medical devices, Health, Interventional cardiology, Medicine, Medical devices, Bare-metal stent, Stent, Health care, Drug-eluting stent

The "Vascular Stent - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vascular Stent - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Vascular Stent market worldwide is projected to grow by US$8.7 Billion, driven by a compounded growth of 7.2%
    Bare-metal Stents, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.4%.
  • The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market.
  • Poised to reach over US$2.7 Billion by the year 2025, Bare-metal Stents will bring in healthy gains adding significant momentum to global growth.

EACTS 2019: Two Prospective Trials Show Positive Clinical and Angiographic Outcomes of Vein Graft External Stenting Up to 3 Years After CABG

Retrieved on: 
Monday, October 7, 2019
Medicine, Medical specialties, Clinical medicine, Cardiac surgery, Coronary artery bypass surgery, Vein graft failure, Minimally invasive cardiac surgery, Drug-eluting stent

The results showed low MACCE rates up to 3 years after CABG, excellent patency rates of vein grafts and significant reduction in the progression of vein graft disease.

Key Points: 
  • The results showed low MACCE rates up to 3 years after CABG, excellent patency rates of vein grafts and significant reduction in the progression of vein graft disease.
  • The VEST III is a randomized controlled trial that enrolled 184 patients in 14 centers in Germany, Austria, Israel and the UK.
  • The majority of patient underwent off pump CABG (77%) and all vein grafts were supported with VEST external stent.
  • Our interim follow up data shows that at 3 years, clinical and angiographic results are superior compared to those observed in published randomized trials."

Drug-eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Retrieved on: 
Thursday, October 3, 2019
Interventional cardiology, Medicine, Medical technology, Medical devices, Drug-eluting stent, Medical equipment, Stent, Cardiology, Steroid eluting sinus stent

Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.

Key Points: 
  • Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.
  • The analyst covers a detailed taxonomy of the drug-eluting stents market, along with an incisive outlook on the competitive scenario.
  • How have leading players in the drug-eluting stents market been able to maintain a distinct competitive edge over their competitors?
  • Information obtained from secondary resources and verified by primary resources have contributed to the compilation of the drug-eluting stents market report.